Personalized medicine and follow-up of therapeutic delivery through exploitation of quantum dot toxicity
- PMID: 28273498
- DOI: 10.1016/j.biomaterials.2017.02.039
Personalized medicine and follow-up of therapeutic delivery through exploitation of quantum dot toxicity
Abstract
Tumor therapy using nanoparticles (NPs) is mainly aimed at using the NPs as carriers for therapeutic drugs or as mediators for external stimuli to generate heat. Recent studies have shown that the toxicity of NPs can also be specifically exploited to kill cancer cells. In the present work, we employ core-only CdTe quantum dots and study their cytotoxicity using a validated high-content screening approach. The data revealed a clear correlation between toxicity and quantum dot degradation, which could be monitored through loss of fluorescence intensity. Based on the in vitro data obtained, the in vivo dose was calculated relative to the estimated number of tumor cells based on luminescence measurements. The obtained results show a clear increase in reproducibility of the therapeutic effect compared to normal conditions, where a set dose of quantum dots was administered regardless of the tumor size. The therapeutic delivery could also be monitored in vivo, where the loss of fluorescence intensity correlated with the anticancer efficacy. The present work highlights the benefits of noninvasive imaging to monitor therapeutic delivery and to optimize treatment via personalized medicine.
Keywords: Nanomedicine; Nanoparticles; Personalized medicine; Quantum dots; Tumor therapy.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Evaluation of toxic effects of CdTe quantum dots on the reproductive system in adult male mice.Biomaterials. 2016 Jul;96:24-32. doi: 10.1016/j.biomaterials.2016.04.014. Epub 2016 Apr 21. Biomaterials. 2016. PMID: 27135714
-
Toxicity assessment of repeated intravenous injections of arginine-glycine-aspartic acid peptide conjugated CdSeTe/ZnS quantum dots in mice.Int J Nanomedicine. 2014 Oct 17;9:4809-17. doi: 10.2147/IJN.S70092. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25378922 Free PMC article.
-
"Jelly dots": synthesis and cytotoxicity studies of CdTe quantum dot-gelatin nanocomposites.Small. 2007 Jul;3(7):1152-6. doi: 10.1002/smll.200700090. Small. 2007. PMID: 17534993 No abstract available.
-
Aqueous phase synthesis of CdTe quantum dots for biophotonics.J Biophotonics. 2011 Jan;4(1-2):9-20. doi: 10.1002/jbio.201000080. Epub 2010 Sep 28. J Biophotonics. 2011. PMID: 20878905 Review.
-
Fluorescence nanoparticles "quantum dots" as drug delivery system and their toxicity: a review.J Drug Target. 2011 Aug;19(7):475-86. doi: 10.3109/1061186X.2010.526227. Epub 2010 Oct 22. J Drug Target. 2011. PMID: 20964619 Review.
Cited by
-
Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion.Int J Mol Sci. 2024 Jan 23;25(3):1396. doi: 10.3390/ijms25031396. Int J Mol Sci. 2024. PMID: 38338674 Free PMC article. Review.
-
Oxidative stress-induced neurotoxicity of quantum dots and influencing factors.Nanomedicine (Lond). 2024;19(11):1013-1028. doi: 10.2217/nnm-2023-0326. Epub 2024 Apr 12. Nanomedicine (Lond). 2024. PMID: 38606672 Review.
-
Berberine-loaded iron oxide nanoparticles alleviate cuprizone-induced astrocytic reactivity in a rat model of multiple sclerosis.Biometals. 2025 Feb;38(1):203-229. doi: 10.1007/s10534-024-00648-4. Epub 2024 Nov 14. Biometals. 2025. PMID: 39543075 Free PMC article.
-
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.J Nanobiotechnology. 2022 Aug 31;20(1):395. doi: 10.1186/s12951-022-01605-4. J Nanobiotechnology. 2022. PMID: 36045386 Free PMC article. Review.
-
Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications.3 Biotech. 2024 Feb;14(2):57. doi: 10.1007/s13205-023-03901-8. Epub 2024 Jan 29. 3 Biotech. 2024. PMID: 38298556 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
